Search images on Google Product Monograph
Active Ingredients:
- bortezomib (bortezomib mannitol boronic ester), 3.5 MG/VIAL
DIN: 02423405
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAVENOUS, SUBCUTANEOUS
Schedule: Prescription
Company: TEVA CANADA LIMITED – official site
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01X - OTHER ANTINEOPLASTIC AGENTS (ATC, WHO)
- L01XG - (ATC, WHO)
- L01XG01 - BORTEZOMIB (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: I.V.:3.5ML/S.C:1.4ML
Pharmaceutical standard: MFR
External Links for Bortezomib For Injection:
Search on Google
- Bortezomib For Injection side effects
- Bortezomib For Injection dosage
- bortezomib side effects
- bortezomib dosage
Teva Canada Limited
Go to Teva website to see drug product details. Sometimes you can find bortezomib for injection photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.